news/blog

forum

social_media

English

_ga_PS14187LHR

_grxs

g_state

FCCDCF

_gid

_grx

_gcl_au

_gat_UA-5594188-58

_iibeat_vt

_iibeat_session

PHPSESSID

OS_CLIENT_ID

Within the commercial generic top-level domain (.com), 'pharma.economictimes.indiatimes.com' is registered and includes subdomain 'pharma.economictimes'. The second-level label 'indiatimes' is 10 characters long containing five vowels alongside 5 consonants. Word splitting yields 2 words: india, times. Average segment length settles at 5 characters. No strong language cues emerged from the frequency lists.

html/d9/83/d98320b5-ecbe-4a0d-9999-1c034ec2283a_fallback.html.gz

Health Insurance Plans: Lilly launches single-dose vials of Zepbound for weight loss to expand US supply, ETPharma

subscribe_email_pop

html/d9/83/d98320b5-ecbe-4a0d-9999-1c034ec2283a.html.gz

frame-ancestors 'self' http://*.indiatimes.com

require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes

script-src 'report-sample' 'nonce-da5dc-FcljSYbWoqchzv3Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/identity-sign-in-google-http, require-trusted-types-for 'script';report-uri https://csp.withgoogle.com/csp/identity-sign-in-google-http

script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsgac:225:0

script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsgac:211:0

script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascgsrsghrgc:72:0

script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:112:0

script-src 'report-sample' 'nonce-SEh5HxcgsTlQUxV4eJOgRw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/identity-sign-in-google-http, require-trusted-types-for 'script';report-uri https://csp.withgoogle.com/csp/identity-sign-in-google-http

script-src 'report-sample' 'nonce-7aX6y5P7Init4_fVVloBUQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/identity-sign-in-google-http, require-trusted-types-for 'script';report-uri https://csp.withgoogle.com/csp/identity-sign-in-google-http

script-src 'report-sample' 'nonce-QrTLJUI3ZrHzwEZOWaeFww' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorServingWebSwitchboardHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport

require-trusted-types-for 'script';report-uri /_/ContributorLoggingHttp/cspreport, script-src 'report-sample' 'nonce-qCfpgx6hzDqQVBkfBt6Vhg' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorLoggingHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorLoggingHttp/cspreport/allowlist

require-trusted-types-for 'script';report-uri /_/ContributorLoggingHttp/cspreport, script-src 'report-sample' 'nonce-PIDG6Qd39B_5Rm2hlFQjtw' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorLoggingHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorLoggingHttp/cspreport/allowlist

script-src 'report-sample' 'nonce-6EZN_sBoLFkJz6G_CK0c-g' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorServingWebSwitchboardHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport

require-trusted-types-for 'script';report-uri /_/ContributorLoggingHttp/cspreport, script-src 'report-sample' 'nonce-O0rZCwbhFGHdVseexsLy0g' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorLoggingHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorLoggingHttp/cspreport/allowlist

require-trusted-types-for 'script';report-uri /_/ContributorLoggingHttp/cspreport, script-src 'report-sample' 'nonce--3kcym7Ld_Jdq1CDmqwciA' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorLoggingHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'unsafe-eval' blob: data: 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorLoggingHttp/cspreport/allowlist

__tcfapiLocator

googlefcInactive

googlefcLoaded

Schaltfläche „Über Google anmelden“

e57f8e3a19d89cc9dc02e8e02bb5a1e77de5d0a77d04fc9c80844a7983a5882c

b4b3478b00186cf8c20f96b561abec31f9179655f46687f864413be69d9b848c

a520a04adee709d390c306df88fb68c3721ebacedad66b5434ebcb15c354077c

c7e1395bfb304036c77c465e348ed498273fc4706d3f9c88cceb1c4f3a08630f

bbd10654b7f9606588db6ecc1d9e04b0e8c6bf81b905ad88d4b24db1890a8b99

311e17c6860034f0d8d3c29066957d45f28cad6305c9f237193696ac228d2205

c1150dd7b41ca229fb6e37dba0e92400c8d8af59962ef84780ea63b724e9a86b

b3c2631d205fb84bf2bf9789df8aef6ad20440b74b7977b26b77ad3251f597d6

5604084a52adbcd1fab88c95847893b69679b75b77bcb0617d8737577fea6c6a

08725e7e8c7373d15c19ad5a3f23d5d6f121572a550c3d4cd2d7c05707a4367f

f6248fc924cc7c8a64e9f9890a117a7d919e70637fcf1aecac80f8bccb5574b4

346d4b9d721cef5c12522449c6845cd1c8a82ee042b53c10d68d10ac076e281a

b5f26053cb668f0de00774f26aa10131624307221969f7d629c3dce1f9b1b5ce

3f5d70ebb4771e315aac3eb517aa60af576ee13d5d4d97defb03cf0c1123f6c1

838e611903a4661b7b94a28f3476b071bff8b268a4691094c0584088f525230b

05f5d5385519a9d97586951121878ff86215907b46a2c14974822d076a9f352e

d1d37ac8b912e6d5d0d7d71d3478d11c6cfaecf4f7a33b3ea5c63a5c1adecff5

ee91deae7e8a0c71958811f366db50129d5e393b3aa04a6711cdeaf0c64b0d99

ae00202b6fe026221227555eb33551fecd1ec03c0f8e33f6727107cb944acc86

9fdb592408e603a43ef404a8d5758669bd32ab6b604e3619e99479dd8e5c709c

17f4aa492f9c408227e318f0c6ab99472fd028631ab4937d563ae3a98ebebec6

febcdd2f1c1f5c4ac21b52d46f51598610c42573fa23ac46221d8f12825ca437

2113e3a2a4de12eba5af8b6607cbfd7cdca35a0c8a4abc98444c592bfa7315e6

c834f9ebbff9b19dd356a892a7aa82a713923b9b78d5a7ce8e180bcbf902bafb

cd40440a170790bced67c4baed5e0bff5517b75e9dc68b3c7509e622667aa3cf

c37e7a4788bda4f30e9263342511dbd1ff0186f929fce2508252d38bd4e3672a

e97b9a5c1d98589a44c450884f66eb8a857f466fcdb18580f6e92086d0ab7816

bc113aee91ddfb7b0c39d64b91f27e5a5ae652699703eafc49360fa64848258f

4fd53a3eefac8cb58a0246b74c6d75274221fc0417af884172d2a8f30d41fcfc

f1a61277e3f902f50ab42015d8b07218db9b7601bb0967e54a52bfdcb4fa7e81

8dc02550768e07cb0f2d184189157d34fd4105e2deceacd2e8d26460f0edd4fe

9fbbf2be16bfab4046ae6a4cd109f82ecad7e095bea7e8f7e19a5c8430ca14b1

7e853e15e6bbfd1d4f3c28b2fa36d3bcaaf4cc4d2a927cc86fffb0434af2748b

c4fd4e7b9ac29a13306e32d94c695a34571b1bd0120c1bf693e86823d8998f1a

31f71ee02ada2c8108c9c204daa879daa58837f075c79c0970bc2babd3c3fd7d

aeef356a762d3755af1ef39d399d8fc80ba28208f7b05d6778fa9c004f9a663c

da3804488bff7e90e6f751dad4b21437c3178e670069c058419c753d8103f520

f8c6a6d8460044b34630088e2e73a6b6106afcb38bf84e69ad8e89a60bcb95d9

1891095e067b1e6774ef4ceb2e96ad33702380c568d9b83280b5f2c48c9c2420

544b508b2ebe55a5a7bc095a8494f6b2a9a9ec8ebb38dda085c283100d87f43e

c442c5505279ba9b8dfe6bf548b2930ace9540cc2e025fcdee7f1e5987064cde

24d39c4a7d11dd02615e0eada2e4b870fd16320854b30f656043a695ddf54663

1846a5da95998e34f6d72633d79d9a5e405b154825e47fbb29c51de02a63f230

3a04fc008338e4ee4cd3f9ece3795ab80bf9f9112714a30cc045336ad569f3a7

a7eadaf179a5e15785914a04b91a5d4a02208e93576fccd8da843ead69784577

7683abdd256af36ec22f206ec5c644c2b4b6b8d3aa5c6afba7218817f7e27107

094571afef807bb8b8f2a5531e7d838b75bb81b5b0c72cfc798dcf7be0efc0c0

75a11da44c802486bc6f65640aa48a730f0f684c5c07a42ba3cd1735eb3fb070

d2d37bf919717c94beba9531c7ecd29e22fbbdbe5ade5e7993ebe00264beb5cf

80f04717f32ea0320c5e8618fbacedd1fee3a8775ad8292140a6113551d4b5b0

0c7178cc6ca34fb18e30f070a5e7a1c287b2d7ccfcba2cfdf06e0f46eda55740

2df4dbb7e86b3a07ae71033f45720377889b10262499353c3ff54cbd2e5682a6

dbcac341b0a00d8b3bdea38eaaafd494dd0bf7e8e986dc96abffb21d48a70b8f

6e3df48d93c5f9ec0ae12ba62ddfff02f0cacb46fa84435d50f962829d8e9995

ETPharma Newsletter
Explore and subscribe to our Daily newsletters

RE-Pharma Awards 2025
As the ET Re-Pharma Awards enters its 5th Edition, we celebrate the visionary 

Follow Us
Get updates of events and latest news from ETPharma on LinkedIn

WhatsApp Channel
Tune in to know the latest updates on the pharma industry

Get sharp, essential insights in Chemicals — focused, timely, actionable.
Join the newsletter

viewport

ZgFICIedNvVZl5pV9EfAUeenwta9vBY0Za_GgmV4zuw

google-site-verification

robots

author

Lilly launches single-dose vials of Zepbound for weight loss to expand US supply

twitter:title

Health Insurance Plans: Around 86% of commercial healthcare plans cover obesity drugs, according to Lilly. Patients not covered for weight loss, such as those on the U.S. government's Medicare health plan for older Americans, may otherwise have to pay more than $1,000 out of pocket for a month's supply of Zepbound.

twitter:description

https://etimg.etb2bimg.com/thumb/msid-112839917,imgsize-39702,width-1200,height=627,overlay-etpharma,resizemode-75/news/pharma-industry/lilly-launches-single-dose-vials-of-zepbound-for-weight-loss-to-expand-us-supply.jpg

twitter:site

twitter:image

health insurance plans, respective list prices, obesity medications, increase supplies of Zepbound, commercial healthcare plans, tirzepatide products, supplies of Zepbound, manufacturing capacity, Medicare health plan, Health news

news_keywords

keywords

description

https://pharma.economictimes.indiatimes.com/news/pharma-industry/lilly-launches-single-dose-vials-of-zepbound-for-weight-loss-to-expand-us-supply/112839917

twitter:card

twitter:image:alt

twitter:url

publish-date

created-date

modified-date

A8o5T4MyEkRZqLA9WeG2XTFdV5tsX2Prg85xyQ+RL1btVuybB1K/EQ+7JUsPK+J32oBMTnsoF9B4A+qTlL6efgQAAABweyJvcmlnaW4iOiJodHRwczovL2FjY291bnRzLmdvb2dsZS5jb206NDQzIiwiZmVhdHVyZSI6IkZlZENtQnV0dG9uTW9kZSIsImV4cGlyeSI6MTc0NDY3NTIwMCwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==

AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==

Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==

A9nrunKdU5m96PSN1XsSGr3qOP0lvPFUB2AiAylCDlN5DTl17uDFkpQuHj1AFtgWLxpLaiBZuhrtb2WOu7ofHwEAAACKeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9

A93bovR+QVXNx2/38qDbmeYYf1wdte9EO37K9eMq3r+541qo0byhYU899BhPB7Cv9QqD7wIbR1B6OAc9kEfYCA4AAACQeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9

A1S5fojrAunSDrFbD8OfGmFHdRFZymSM/1ss3G+NEttCLfHkXvlcF6LGLH8Mo5PakLO1sCASXU1/gQf6XGuTBgwAAACQeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiQUlQcm9tcHRBUElNdWx0aW1vZGFsSW5wdXQiLCJleHBpcnkiOjE3NzQzMTA0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9

HSTS header missing - vulnerable to protocol downgrade attacks

CSP header missing - vulnerable to XSS attacks

child-src 'none';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources 'self';trusted-types;worker-src blob: 'self';frame-ancestors 'none';

child-src https:  chrome-untrusted://new-tab-page/ chrome-untrusted://ntp-microsoft-auth/;connect-src chrome://resources chrome://theme 'self';default-src 'self';font-src chrome://resources 'self';img-src chrome://resources chrome://theme chrome://image chrome://favicon2 chrome://app-icon chrome://extension-icon chrome://fileicon blob: data: 'self';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources chrome://webui-test 'self';style-src chrome://resources chrome://theme 'self' 'unsafe-inline';trusted-types parse-html-subset sanitize-inner-html static-types webui-test-script webui-test-html polymer-html-literal polymer-template-event-attribute-policy lit-html-desktop;frame-ancestors 'none';

child-src 'none';object-src 'none';require-trusted-types-for 'script';script-src chrome://resources 'self';trusted-types;frame-ancestors 'none';

base-uri 'none';child-src https:;form-action https://ogs.google.com https://*.corp.google.com;object-src 'none';script-src 'self' 'unsafe-inline' https:;frame-ancestors chrome://new-tab-page/

Tucows Domains Inc.

INDIATIMES.COM


            var hdomain='indiatimes.com'; 
        


// To handle GA issue on unknown pages 
if(typeof ga != "undefined") {
  function ga(){

  }
}
var hasUserAllowedInEU = function(trackingParam){
  var result = true;

  if(trackingParam) {
    trackingParam = trackingParam.toLowerCase();
    var userPreference = localStorage.getItem('userPreference');
    var configParam = 'config.' + trackingParam;
    
    // IF user Gave the consent to track GA
    if(userPreference){
        userPreference = JSON.parse(userPreference);

        if(typeof userPreference.data != "undefined" && userPreference.data != "" && typeof userPreference.data[configParam] != "undefined" && userPreference.data[configParam] != "1"){
          result = false;
        }
    }
  }
  return result;
};

var isGTMLoadValid = typeof analytics_gtm_id != "undefined" && analytics_gtm_id && hasUserAllowedInEU('ga');
if(isGTMLoadValid && isGTMLoadValid != "") {
  // Load GTM Script
  window.dataLayer = window.dataLayer || [];
}



                                            var news_msid = 112839917;
                                            console.log(news_msid);
                                        


    window.ad_divs = ["div-gpt-ad-pharma-1679038176702-1","div-gpt-ad-pharma-1679038176703-1"];
    window.news_video_txt = 'content';
    window.next_story_man1 = JSON.parse('null');



    window.ad_divs = ["div-gpt-ad-pharma-1679038176198-1","div-gpt-ad-pharma-1679038176199-1"];
    window.news_video_txt = 'content';
    window.next_story_man1 = JSON.parse('null');



            executeOnReady(function() {
            var ad_time_delay = deviceType === 'desktop' ? (ad_delay ? parseInt(ad_delay) : 6000) : 6000;
            setTimeout(function() {
                loadScript('https://st.etb2bimg.com/Themes/Release/js/app.featured-section.min.js?mod=3052');
            }, ad_time_delay);
            if (!['unsubscribe', 'pageNotFound'].includes(pageLabelName)) {
                // setTimeout(function() {
                    loadScript('https://st.etb2bimg.com/Themes/Release/js/app.analytics.min.js?mod=3052');
                // }, 9000);
            }
        });
                $(window).on('scroll', function() {
        unvielImg();
        $('.news-categories .item_cat_tiles .mobile-view, .news-categories .contents .desktop-view').addClass('ficons');
        $('.article-divider__inner__content').addClass('next-story-icon');
        $('body .main-content .calender-icon, body .main-content .location-icon, body .main-content .duration-icon, body .main-content .submission-icon').addClass('sprite-icon-img');
        $('body footer.footer').removeClass('hide');
    });
    if ($('body').hasClass('page-newsDetail') || $('body').hasClass('page-podcastListingDetail') || $('body').hasClass('page-videoListingDetail')) {
        $('body').addClass('inpage-promo-abtest');
        $('body').addClass('detail-article-inpage');
    } else {
        $('body').addClass('page-longInpage');
        $('body').addClass('inpage-promo-home-abtest');
    }

    if (($('.page-newsdetail').length) || $('.page-newsDetail').length || $('.page-blogdetail').length || $('.page-blogDetail').length || $('.page-liveBlogDetail').length) {
        loadScript(resourceURLMap.js["news_detail"]);
    }
    
    var pageLabelArr = ['homepage', 'latestNews', 'sectionListing', 'tagListing', 'agencyNewsListing'];
    var load_timeout = pageLabelArr.includes(pageLabelName) ? 8000 : 100;
    document.querySelector('body')?.classList.add(headerWithoutAds);
    document.querySelector('body')?.classList.add(portalTheme);
    document.querySelector('body')?.classList.add(portalTheme_two);
    document.querySelector('body')?.classList.add(hambergerStatus);
    document.querySelector('body')?.classList.add(ai_portalTheme);
    if ($('.page-awardsNew').length) {
        document.querySelector('body')?.classList.add('dark-layout-theme');
        $('.site-header__logo .floating-logo-view').attr('src', THEME_PATH + '/theme4/images/white-logos/' + ET_PORTAL + '-logo-header.svg?mod=14');
        $('.site-header__hamburger .hamberger-icon').addClass('white');
        deviceType !== 'desktop' ? $('.dark-layout-theme .site-header').addClass('remove-backdrop') : '';
    }

    if ($('.flexi-audio').length || $('.flexi-video').length || $('.video-section').length) {
        setTimeout(() => {
            loadScript('https://imasdk.googleapis.com/js/sdkloader/ima3.js');
            loadScript('https://tvid.in/sdk/loader.js');
            loadScript(resourceURLMap.js["slikeplayer"]);
        }, load_timeout);
    }
    if ($('.twitter-tweet').length){
        loadScript('https://platform.twitter.com/widgets.js');
    }
    


    setTimeout(function() {
        var script = document.createElement("script")
        script.type = "text/javascript";
        // script.src = 'https://cdn.cookielaw.org/scripttemplates/otSDKStub.js';
        // script.setAttribute("data-domain-script", "018fc3a2-aa8b-7640-a23d-89a6d1f9b586");
        script.src = 'https://securepubads.g.doubleclick.net/tag/js/gpt.js?network-code=7176';
        //document.getElementsByTagName("head")[0].appendChild(script);

        //function OptanonWrapper() {}

        //For GDPR:
        
        window.googlefc?.callbackQueue?.push({
            'CONSENT_DATA_READY': () => {
                __tcfapi('addEventListener', 2.2, (consentData, success) => {
                    if (consentData.gdprApplies === true) {
                        if (consentData.eventStatus === 'useractioncomplete' || consentData.eventStatus === 'tcloaded') {
                            // Handle user action
                            // or handle existing user consent
                            // consent status to be checked by consentData object 
                        } else {
                            // Handle unknown consent state
                        }
                    } else {
                        // GDPR does not apply (No consent required)
                    }
                });
            }
        });

        //For CCPA:
        window.googlefc?.callbackQueue?.push({
            'INITIAL_CCPA_DATA_READY': () => {
                switch (googlefc.ccpa.getInitialCcpaStatus()) {
                    case googlefc.ccpa.InitialCcpaStatusEnum.CCPA_DOES_NOT_APPLY:
                        console.log("User is not CPRA eligible.");
                        break;
                    case googlefc.ccpa.InitialCcpaStatusEnum.NOT_OPTED_OUT:
                        console.log("User is CPRA eligible and has not opted out.");
                        break;
                    case googlefc.ccpa.InitialCcpaStatusEnum.OPTED_OUT:
                        console.log("User is CPRA eligible and has opted out.");
                        break;
                }
            }
        });

    }, 7000);


Home

News

Pharma Industry

By Patrick WingroveLondon: Eli Lilly said it has begun selling single-dose vials of its popular weight-loss drug Zepbound in the U.S., aimed at patients who cannot get the cost of the medicine reimbursed through their health insurance plans. The 2.5 milligram and 5 mg vials, which are the two lowest available doses of Zepbound, will be available through the drugmaker's website LillyDirect at respective list prices of $399 and $549 for a month's supply, the company said. Lilly and Danish rival Novo Nordisk have been struggling to make enough of their obesity medications to meet soaring demand, with both Zepbound and Novo's Wegovy having been listed as in shortage by the U.S. FDA for much of this year. The Food and Drug Administration now lists all doses of Lilly's Zepbound, known chemically as tirzepatide, as available but has not removed it from the shortage list. The lowest dose of Wegovy is still listed as in shortage. Patrik Jonsson, Lilly's president of cardiometabolic health, said in an interview that the launch of these vials will significantly increase supplies of Zepbound in the U.S. "We are very confident with both the auto-injectors and the vials that we will be able to supply the needs in the U.S. marketplace," he said, adding that a big chunk of patients do not progress to higher doses of Zepbound than 5mg during treatment. Lilly said the prices of these vials represented a 50 per cent  discount on those of all other obesity medicines in the GLP-1 class. It has previously said patients who are not covered for Zepbound can get the drug in a pen through LillyDirect for as little as $550. Around 86 per cent of commercial healthcare plans cover obesity drugs, according to Lilly. Patients not covered for weight loss, such as those on the U.S. government's Medicare health plan for older Americans, may otherwise have to pay more than $1,000 out of pocket for a month's supply of Zepbound. Lilly has already launched vials of its tirzepatide products in other countries including Australia, Canada and Poland, Jonsson said. The company earlier this month raised its sales forecast for the year by $3 billion on the back of increased manufacturing capacity and supplies of Zepbound and diabetes treatment Mounjaro, which is also tirzepatide. (Reporting by Patrick Wingrove Editing by Bill Berkrot)

​Around 86% of commercial healthcare plans cover obesity drugs, according to Lilly. Patients not covered for weight loss, such as those on the U.S. government's Medicare health plan for older Americans, may otherwise have to pay more than $1,000 out of pocket for a month's supply of Zepbound.

ETPharma An initiative of The Economic Times

ETPharma

var growthRxPageViewObj={url:google_tag_manager["rm"]["187587720"](7),pageType:google_tag_manager["rm"]["187587720"](8),pageTitle:google_tag_manager["rm"]["187587720"](9),news_authors:google_tag_manager["rm"]["187587720"](10),news_agency:google_tag_manager["rm"]["187587720"](11),pageGroup:google_tag_manager["rm"]["187587720"](12),news_category:google_tag_manager["rm"]["187587720"](13),pageId:google_tag_manager["rm"]["187587720"](14),published_date:google_tag_manager["rm"]["187587720"](15),published_time:google_tag_manager["rm"]["187587720"](16),last_update_date:google_tag_manager["rm"]["187587720"](17),special_coverage:google_tag_manager["rm"]["187587720"](18),video_embed:google_tag_manager["rm"]["187587720"](19),audio_embed:google_tag_manager["rm"]["187587720"](20),
nature_of_content:google_tag_manager["rm"]["187587720"](21),news_keywords:google_tag_manager["rm"]["187587720"](22),portal_in_portal:google_tag_manager["rm"]["187587720"](23),subProject:google_tag_manager["rm"]["187587720"](24),pageAccess:google_tag_manager["rm"]["187587720"](25),utm_source:google_tag_manager["rm"]["187587720"](26),utm_medium:google_tag_manager["rm"]["187587720"](27),utm_campaign:google_tag_manager["rm"]["187587720"](28),agencycode:google_tag_manager["rm"]["187587720"](29)};for(i in growthRxPageViewObj)growthRxPageViewObj[i]||delete growthRxPageViewObj[i];grx("track","page_view",growthRxPageViewObj);

var growthRxPageViewObj={url:google_tag_manager["rm"]["187587720"](62),pageType:google_tag_manager["rm"]["187587720"](63),pageTitle:google_tag_manager["rm"]["187587720"](64),news_authors:google_tag_manager["rm"]["187587720"](65),news_agency:google_tag_manager["rm"]["187587720"](66),pageGroup:google_tag_manager["rm"]["187587720"](67),news_category:google_tag_manager["rm"]["187587720"](68),pageId:google_tag_manager["rm"]["187587720"](69),published_date:google_tag_manager["rm"]["187587720"](70),published_time:google_tag_manager["rm"]["187587720"](71),last_update_date:google_tag_manager["rm"]["187587720"](72),special_coverage:google_tag_manager["rm"]["187587720"](73),video_embed:google_tag_manager["rm"]["187587720"](74),audio_embed:google_tag_manager["rm"]["187587720"](75),
nature_of_content:google_tag_manager["rm"]["187587720"](76),news_keywords:google_tag_manager["rm"]["187587720"](77),portal_in_portal:google_tag_manager["rm"]["187587720"](78),subProject:google_tag_manager["rm"]["187587720"](79),pageAccess:google_tag_manager["rm"]["187587720"](80),utm_source:google_tag_manager["rm"]["187587720"](81),utm_medium:google_tag_manager["rm"]["187587720"](82),utm_campaign:google_tag_manager["rm"]["187587720"](83),agencycode:google_tag_manager["rm"]["187587720"](84)};for(i in growthRxPageViewObj)growthRxPageViewObj[i]||delete growthRxPageViewObj[i];grx("track","page_view",growthRxPageViewObj);

var growthRxPageViewObj={url:google_tag_manager["rm"]["187587720"](89),pageType:google_tag_manager["rm"]["187587720"](90),pageTitle:google_tag_manager["rm"]["187587720"](91),news_authors:google_tag_manager["rm"]["187587720"](92),news_agency:google_tag_manager["rm"]["187587720"](93),pageGroup:google_tag_manager["rm"]["187587720"](94),news_category:google_tag_manager["rm"]["187587720"](95),pageId:google_tag_manager["rm"]["187587720"](96),published_date:google_tag_manager["rm"]["187587720"](97),published_time:google_tag_manager["rm"]["187587720"](98),last_update_date:google_tag_manager["rm"]["187587720"](99),special_coverage:google_tag_manager["rm"]["187587720"](100),video_embed:google_tag_manager["rm"]["187587720"](101),audio_embed:google_tag_manager["rm"]["187587720"](102),
nature_of_content:google_tag_manager["rm"]["187587720"](103),news_keywords:google_tag_manager["rm"]["187587720"](104),portal_in_portal:google_tag_manager["rm"]["187587720"](105),subProject:google_tag_manager["rm"]["187587720"](106),pageAccess:google_tag_manager["rm"]["187587720"](107),utm_source:google_tag_manager["rm"]["187587720"](108),utm_medium:google_tag_manager["rm"]["187587720"](109),utm_campaign:google_tag_manager["rm"]["187587720"](110),agencycode:google_tag_manager["rm"]["187587720"](111)};for(i in growthRxPageViewObj)growthRxPageViewObj[i]||delete growthRxPageViewObj[i];grx("track","page_view",growthRxPageViewObj);

HSTS

Comscore

LinkedIn

Google

Google authentication and security services

First-Party Tracking

✅ Low Risk - https://pharma.economictimes.indiatimes.com/news/pharma-industry/lilly-launches-single-dose-vials-of-zepbound-for-weight-loss-to-expand-us-supply/112839917

Requests	IP Address	Location	AS Autonomous System
66	23.210.124.135	Frankfurt am Main, Hesse, Germany	AS16625AKAMAI-AS
40	184.24.77.28	Frankfurt am Main, Hesse, Germany	AS20940Akamai International B.V.
22	23.37.40.201	Frankfurt am Main, Hesse, Germany	AS16625AKAMAI-AS
19	23.36.162.142	Frankfurt am Main, Hesse, Germany	AS20940Akamai International B.V.
8	142.250.185.131	United States	AS15169GOOGLE
7	23.36.162.138	Frankfurt am Main, Hesse, Germany	AS20940Akamai International B.V.
6	64.233.167.84	United States	AS15169GOOGLE
6	142.251.140.174	United States	AS15169GOOGLE
6	18.244.18.32	United States	AS16509AMAZON-02
5	150.171.22.12	United States	AS8075MICROSOFT-CORP-MSN-AS-BLOCK
184	73	-	-

Security Scan Report: pharma.economictimes.indiatimes.com

Summary

AI Security Verdict

Safe Website

Safety Factors

Details

Screenshot

Page Load Overview

Language Analysis

Primary Language

Detection Details

Website Classification

Primary Category

All Detected Categories

Detected Features

Domain & IP Information

Detected Technologies1

Content Similarity HashesFor malware variant detection

Image Hashes

Perceptual Hashes

Other Hashes

Scan History